Researchers at the Icahn School of Medicine at Mount Sinai have developed an advanced artificial intelligence (AI)-driven tool to improve the management and prognosis of prostate cancer. Details on the findings were reported in European Urology.
New AI tool could reshape prostate cancer care by identifying those at higher risk of rapid disease progression
